Premium
Illness intrusiveness among survivors of autologous blood and marrow transplantation
Author(s) -
Schimmer Aaron D.,
Elliott Mary E.,
Abbey Susan E.,
Raiz Lisa,
Keating Armand,
Beanlands Heather J.,
McCay Elizabeth,
Messner Hans A.,
Lipton Jeff H.,
Devins Gerald M.
Publication year - 2001
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(20011215)92:12<3147::aid-cncr10168>3.0.co;2-c
Subject(s) - medicine , beck depression inventory , rating scale , transplantation , intrusiveness , severity of illness , physical therapy , depression (economics) , anxiety , psychiatry , psychology , social psychology , developmental psychology , economics , macroeconomics
BACKGROUND Illness‐induced disruptions to lifestyles, activities, and interests (i.e., illness intrusiveness) compromise subjective well‐being. The authors measured illness intrusiveness in autologous blood and bone marrow transplantation (ABMT) survivors and compared the results with survivors of solid organ transplants. METHODS Forty‐four of 64 consecutive ABMT survivors referred to the University of Toronto ABMT long‐term follow‐up clinic completed the Illness Intrusiveness Ratings Scale (IIRS), the Affect Balance Scale (ABS), the Atkinson Life Happiness Rating (ATKLH), the Beck Hopelessness Scale (BHS), and the Center for Epidemiologic Studies Depression (CES‐D) Scale. Mean time from ABMT to evaluation was 4.6 ± 2.8 years. All patients were in remission or had stable disease at the time of evaluation. Autologous blood and bone marrow transplantation patients' IIRS scores were compared with scores reported by recipients of kidney ( n = 357), liver ( n = 150), lung ( n = 77), and heart ( n = 60) transplants. RESULTS Mean IIRS score for the 44 ABMT patients was 37.2 ± 17 (maximum possible score, 91; minimum possible score, 13). Higher IIRS scores correlated with lower scores on the ABS (r = −0.54; P < 0.0001), and ATKLH (r = −0.44; P = 0.004), and with higher scores on the BHS (r = 0.58; P < 0.0001) and CES‐D (r = 0.48; P < 0.0001). The authors compared IIRS scores from the ABMT survivors with scores from recipients of solid organ transplants. Scores were corrected for age, gender, and time from transplant to evaluation. Corrected mean IIRS scores for the marrow (37.5), kidney (38.9), heart (40.0), lung (30.1), and liver (32.3) transplant recipients differed significantly ( P < 0.0001 by analysis of covariance). Higher scores among marrow, kidney, and heart transplant survivors were caused by increased scores in the instrumental domain of the IIRS that measures disruptions in health, work, financial situation, and active recreation. CONCLUSIONS Despite achieving a remission after ABMT, patients continue to experience illness intrusiveness compromising subjective well‐being. Cancer 2001;92:3147–54. © 2001 American Cancer Society.